Estrogen, menopause, and the aging brain: How basic neuroscience can inform hormone therapy in women

Journal of Neuroscience

Volumn 26, Issue 41, 2006, Pages 10332-10348

  Morrison, John H ^a   Brinton, Roberta D ^b   Schmidt, Peter J ^c   Gore, Andrea C ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Cerebral cortex; Cognition; Estradiol; Hippocampus; Hypothalamus; Mood; Neuroprotection

Indexed keywords

ESTROGEN; SEX HORMONE;

AGING; BEHAVIOR CHANGE; COGNITION; CONFERENCE PAPER; DEMENTIA; FEMALE; HORMONAL THERAPY; HORMONE RELEASE; HUMAN; MENOPAUSE; MOOD DISORDER; NEUROPROTECTION; NEUROSCIENCE; PRIORITY JOURNAL; SEXUAL FUNCTION;

AGING; ANIMALS; BRAIN; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; NEUROSCIENCES;

EID: 33749852756     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3369-06.2006     Document Type: Conference Paper

References (188)

1. Adams MM, Shah RA, Janssen WG, Morrison JH (2001a) Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. Proc Natl Acad Sci USA 98:8071-8076.
2. Adams MM, Oung T, Morrison JH, Gore AC (2001b) Length of postovariectomy interval and age, but not estrogen replacement, regulate N-methyl-D-aspartate receptor mRNA levels in the hippocampus of female rats. Exp Neurol 170:345-356.
3. Adams MM, Fink SE, Shah RA, Janssen WG, Hayashi S, Milner TA, McEwen BS, Morrison JH (2002) Estrogen and aging affect the subcellular distribution of estrogen receptor-alpha in the hippocampus of female rats. J Neurosci 22:3608-3614.
4. Adams MM, Fink SE, Janssen WG, Shah RA, Morrison JH (2004) Estrogen modulates synaptic N-methyl-D-aspartate receptor subunit distribution in the aged hippocampus. J Comp Neurol 474:419-426.
5. Akama KT, McEwen BS (2003) Estrogen stimulates postsynaptic density-95 rapid protein synthesis via the Akt/protein kinase B pathway. J Neurosci 23:2333-2339.
6. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, et al. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291:1701-1712.
7. Ariazi EA, Ariazi JL, Cordera F, Jordan VC (2006) Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 6:181-202.
8. Avis NE, Stellato R, Crawford S, Bromberger J, Ganz P, Cain V, Kagawa-Singer M (2001) Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 52:345-356.
9. Bellino FL, Wise PM (2003) Nonhuman primate models of menopause workshop. Biol Reprod 68:10-18.
10. Berman KF, Schmidt PJ, Rubinow DR, Danaceau MA, Van Horn JD, Esposito G, Ostrem JL, Weinberger DR (1997) Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci USA 94:8836-8841.
11. Bi R, Broutman G, Foy MR, Thompson RF, Baudry M (2000) The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci USA 97:3602-3607.
12. Bonavera JJ, Swerdloff RS, Hikim APS, Lue YH, Wang C (1998) Aging results in attenuated gonadotropin releasing hormone-luteinizing hormone axis responsiveness to glutamate receptor agonist N-methyl-D-aspartate. J Neuroendocrinol 10:93-99.
13. Brann DW, Mahesh VB (2005) The aging reproductive neuroendocrine axis. Steroids 70:273-283.
14. Breitner JCS, Zandi PP (2003) Effects of estrogen plus progestin on risk of dementia. JAMA 290:1706-1707.
15. Brewer GJ, Reichensperger JD, Brinton RD (2006) Prevention of age-related dysregulation of calcium dynamics by estrogen in neurons. Neurobiol Aging 27:306-317.
16. Brinton RD (2004) Impact of estrogen therapy on Alzheimer's disease: a fork in the road? CNS Drugs 18:405-422.
17. Brinton RD (2005) Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann NY Acad Sci 1052:57-74.
18. Brinton RD, Nilsen J (2003) Effects of estrogen plus progestin on risk of dementia. JAMA 290:1706; author reply 1707-1708.
19. Brinton RD, Proffitt P, Tran J, Luu R (1997) Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism. Exp Neurol 147:211-220.
20. Brinton RD, Chen S, Montoya M, Hsieh D, Minaya J, Kim J, Chu HP (2000) The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective. Neurobiol Aging 21:475-496.
21. Bromberger JT, Meyer PM, Kravitz HM, Sommer B, Cordal A, Powell L, Ganz PA, Sutton-Tyrrell K (2001) Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health 91:1435-1442.
22. Brookmeyer R, Gray S, Kawas C (1998) Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88:1337-1342.
23. Bryant DN, Sheldahl LC, Marriott LK, Shapiro RA, Dorsa DM (2006) Multiple pathways transmit neuroprotective effects of gonadal steroids. Endocrine 29:199-207.
24. Burger HG, Dudley EC, Cui J, Dennerstein L, Hopper JL (2000) A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 85:2832-2838.
25. Burke SN, Barnes CA (2006) Neural plasticity in the ageing brain. Nat Rev Neurosci 7:30-40.
26. Chakraborty TR, Ng L, Gore AC (2003a) Colocalization and hormone regulation of estrogen receptor alpha and NMDA receptor in the hypothalamus of female rats. Endocrinology 144:299-305.
27. Chakraborty TR, Ng L, Gore AC (2003b) Age-related changes in estrogen receptor beta in rat hypothalamus: a quantitative analysis. Endocrinology 144:4164-4171.
28. Chakraborty TR, Hof PR, Ng L, Gore AC (2003c) Stereologic analysis of estrogen receptor alpha (ERα) expression in rat hypothalamus and its regulation by aging and estrogen. J Comp Neurol 466:409-421.
29. Chen S, Nilsen J, Brinton R (2006) Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology, in press.
30. Choi JM, Romeo RD, Brake WG, Bethea CL, Rosenwaks Z, McEwen BS (2003) Estradiol increases pre- and post-synaptic proteins in the CA1 region of the hippocampus in female rhesus macaques (Macaca mulatta). Endocrinology 144:4734-4738.
31. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL (2006) Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 63:385-390.
32. Cordey M, Gundimeda U, Gopalakrishna R, Pike CJ (2003) Estrogen activates protein kinase C in neurons: role in neuroprotection. J Neurochem 84:1340-1348.
33. Davison SL, Bell R, Donath S, Montalto JG, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847-3853.
34. Dennerstein L, Burrows GD, Wood C, Hyman G (1980) Hormones and sexuality: effect of estrogen and progestogen. Obstet Gynecol 56:316-322.
35. Eiken P, Kolthoff N (1995) Compliance with long-term oral hormonal replacement therapy. Maturitas 22:97-103.
36. Elston GN (2003) Cortex, cognition and the cell: new insights into the pyramidal neuron and prefrontal function. Cereb Cortex 13:1124-1138.
37. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2959-2968.
38. Ettinger B, Pressman A (1999) Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy. Am J Manag Care 5:779-785.
39. Foy MR, Xu J, Xie X, Brinton RD, Thompson RF, Berger TW (1999) 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J Neurophysiol 81:925-929.
40. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L (2004) Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61:62-70.
41. Freeman EW, Sammel MD, Lin H, Nelson DB (2006) Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63:375-382.
42. Gabor R, Nagle R, Johnson DA, Gibbs RB (2003) Estrogen enhances potassium-stimulated acetylcholine release in the rat hippocampus. Brain Res 962:244-247.
43. Gao S, Hendrie HC, Hall KS, Hui S (1998) The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 55:809-815.
44. Garcia-Segura LM, Cardona-Gomez P, Naftolin F, Chowen JA (1998) Estradiol upregulates Bcl-2 expression in adult brain neurons. NeuroReport 9:593-597.
45. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B (2006) Mild cognitive impairment. Lancet 367:1262-1270.
46. Gazzaley AH, Weiland NG, McEwen BS, Morrison JH (1996) Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J Neurosci 16:6830-6838.
47. Gibbs RB (2000) Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 21:107-116.
48. Gibbs RB (2002) Basal forebrain cholinergic neurons are necessary for estrogen to enhance acquisition of a delayed matching-to-position T-maze task. Horm Behav 42:245-257.
49. Gibbs RB, Gabor R (2003) Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res 74:637-643.
50. Goldman-Rakic PS (1988) Topography of cognition: parallel distributed networks in primate association cortex. Annu Rev Neurosci 11:137-156.
51. Gore AC (2001) Gonadotropin-releasing hormone neurons, NMDA receptors, and their regulation by steroid hormones across the reproductive life cycle. Brain Res Rev 37:235-248.
52. Gore AC (2002) GnRH: the master molecule of reproduction. Norwell, MA: Kluwer Academic.
53. Gore AC (2004) GnRH neurons: multiple inputs, multiple outputs. Endocrinology 145:4016-4017.
54. Gore AC, Yeung G, Morrison JH, Oung T (2000a) Neuroendocrine aging in the female rat: the changing relationship of hypothalamic gonadotropin-releasing hormone neurons and N-methyl-D-aspartate receptors. Endocrinology 141:4757-4767.
55. Gore AC, Oung T, Yung S, Flagg RA, Woller MJ (2000b) Neuroendocrine mechanisms for reproductive senescence in the female rat: gonadotropin-releasing hormone neurons. Endocrine 13:315-323.
56. Gore AC, Oung T, Woller MJ (2002) Age-related changes in hypothalamic gonadotropin-releasing hormone (GnRH) and NMDA receptor gene expression and their regulation by estrogen in the female rat. J Neuroendocrinol 14:300-309.
57. Gore AC, Windsor-Engnell BM, Terasawa E (2004) Menopausal increases in pulsatile gonadotropin-releasing hormone (GnRH) release in a nonhuman primate (Macaca mulatta). Endocrinology 145:4653-4659.
58. Gould E, Woolley CS, Frankfurt M, McEwen BS (1990) Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 10:1286-1291.
59. Hall JE, Gill S (2001) Neuroendocrine aspects of aging in women. Endocrinol Metab Clin North Am 30:631-646.
60. Hao J, Janssen WG, Tang Y, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp PR, Kordower JH, Hof PR, Morrison JH (2003) Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol 465:540-550.
61. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D (2001) Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20:21-35.
62. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR (2000) Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54:295-301.
63. Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L (2003) Estrogen exposures and memory at midlife: a population-based study of women. Neurology 60:1369-1371.
64. Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA (2005) Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 76:103-105.
65. Herbison AE, Skinner DC, Robinson JE, King IS (1996) Androgen receptor-immunoreactive cells in ram hypothalamus: distribution and colocalization patterns with gonadotropin-releasing hormone, somatostatin and tyrosine hydroxylase. Neuroendocrinology 63:120-131.
66. Hogervorst E, Yaffe K, Richards M, Huppert F (2002) Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev CD003122.
67. Hojo Y, Hattori TA, Enami T, Furukawa A, Suzuki K, Ishii HT, Mukai H, Morrison JH, Janssen WG, Kominami S, Harada N, Kimoto T, Kawato S (2004) Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc Natl Acad Sci USA 101:865-870.
68. 125I-estrogen binding in luteinizing hormone-releasing hormone neurons of the rat brain. Endocrinology 141:3506-3509.
69. Janssen WG, Yildirim M, Lou WWY, McEwen BS, Milner TA, Morrison JH (2006) Estrogen receptor β is affected by estrogen and aging in CA1sr region of female rat hippocampus. Soc Neurosci Abstr 32:659.17.
70. Kasai H, Matsuzaki M, Noguchi J, Yasumatsu N, Nakahara H (2003) Structure-stability-function relationships of dendritic spines. Trends Neurosci 26:360-368.
71. Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA (2000) Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 74:279-285.
72. Kawakami S, Hirunagi K, Ichikawa M, Tsukamura H, Maeda K-I (1998a) Evidence for terminal regulation of GnRH release by excitatory amino acids in the median eminence in female rats: a dual immunoelectron microscopic study. Endocrinology 139:1458-1461.
73. Kawakami S, Ichikawa M, Murahashi K, Hirunagi K, Tsukamura H, Maeda K (1998b) Excitatory amino acids act on the median eminence nerve terminals to induce gonadotropin-releasing hormone release in female rats. Gen Comp Endocrinol 112:372-382.
74. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521.
75. Keenan PA, Ezzat WH, Ginsburg K, Moore GJ (2001) Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 26:577-590.
76. Khachaturian ZS (1994) Calcium hypothesis of Alzheimer's disease and brain aging. Ann NY Acad Sci 747:1-11.
77. Krohn PL (1955) Ovarian homotransplantation. Ann NY Acad Sci 59:443-447.
78. Kudwa AE, Michopoulos V, Gatewood JD, Rissman EF (2006) Roles of estrogen receptors alpha and beta in differentiation of mouse sexual behavior. Neuroscience 138:921-928.
79. Lacreuse A (2006) Effects of ovarian hormones on cognitive function in nonhuman primates. Neuroscience 138:859-867.
80. LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3:862-872.
81. 2+ channel activity in brain aging and dementia. Hormonal and pharmacologic modulation. Ann NY Acad Sci 747:351-364.
82. LeBlanc ES, Janowsky J, Chan BK, Nelson HD (2001) Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285:1489-1499.
83. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC (2006) Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 13:46-56.
84. Lloyd JM, Hoffman GE, Wise PM (1994) Decline in immediate early gene expression in gonadotropin-releasing hormone neurons during proestrus in regularly cycling, middle-aged rats. Endocrinology 134:1800-1805.
85. Maffucci JA, Gore AC (2006) Age-related changes in hormones and their receptors in animal models of female reproductive senescence. In: Handbook of models for human aging (Conn PM, ed), pp 533-552. New York: Elsevier.
86. Maki PM (2006) Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience 138:1027-1030.
87. Maki PM, Zonderman AB, Resnick SM (2001) Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 158:227-233.
88. Mannella P, Brinton RD (2006) Estrogen receptor protein interaction with PI3K leads to activation of pAkt and pERK in the same population of cortical neurons: a unified mechanism of estrogen action. J Neurosci 26:9439-9447.
89. Manson JE, Bassuk SS, Harman SM, Brinton EA, Cedars MI, Lobo R, Merriam GR, Miller VM, Naftolin F, Santoro N (2006) Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 13:139-147.
90. Markowska AL, Savonenko AV (2002) Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci 22:10985-10995.
91. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P (1996) Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 143:971-978.
92. McEwen B (2002) Estrogen actions throughout the brain. Recent Prog Horm Res 57:357-384.
93. McEwen B, Akama K, Alves S, Brake WG, Bulloch K, Lee S, Li C, Yuen G, Milner TA (2001) Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Natl Acad Sci USA 98:7093-7100.
94. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA (2001) Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230-4251.
95. Mikkola TS, Clarkson TB (2002) Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 53:605-619.
96. Miller BH, Gore AC (2002) N-methyl-D-aspartate receptor subunit expression in gonadotropin-releasing hormone neurons changes during reproductive senescence in the female rat. Endocrinology 143:3568-3574.
97. Milner TA, McEwen BS, Hayashi S, Li CJ, Reagan LP, Alves SE (2001) Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J Comp Neurol 429:355-371.
98. Milner TA, Ayoola K, Drake CT, Herrick SP, Tabori NE, McEwen BS, Warrier S, Alves SE (2005) Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J Comp Neurol 491:81-95.
99. Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, Pfaff DW, Ogawa S, Rohrer SP, Schaeffer JM, McEwen BS, Alves SE (2003) Immunolocalization of estrogen receptor β in the mouse brain: comparison with estrogen receptor α. Endocrinology 144:2055-2067.
100. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M (2004) Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55:406-412.
101. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283:1007-1015.
102. Murphy DD, Segal M (1996) Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 16:4059-4068.
103. Murphy DD, Cole NB, Greenberger V, Segal M (1998) Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci 18:2550-2559.
104. Myers LS, Dixen J, Morrissette D, Carmichael M, Davidson JM (1990) Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab 70:1124-1131.
105. Nathorst-Boos J, von Schoultz B, Carlstrom K (1993a) Elective ovarian removal and estrogen replacement therapy: effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 14:283-293.
106. Nathorst-Boos J, Wiklund I, Mattsson LA, Sandin K, von Schoultz B (1993b) Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women. Acta Obstet Gynecol Scand 72:656-660.
107. Nilsen J, Brinton RD (2003) Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci USA 100:10506-10511.
108. Nilsen J, Brinton RD (2004) Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord 3:297-313.
109. Nilsen J, Chen S, Brinton RD (2002) Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res 930:216-234.
110. Nilsen J, Deng J, Brinton RD (2005) Impact of clinically relevant progestins on the neural effects of estradiol and the signaling pathways involved. Drug News Perspect 18:545-553.
111. Nilsen J, Irwin RW, Brinton RD (2006a) Brain mitochondria as therapeutic target for the prevention of Alzheimer's pathology. Alzheimer's and Dementia 2[Suppl 3]:S632-S633.
112. Nilsen J, Morales A, Brinton RD (2006b) Medroxyprogesterone acetate exacerbates glutamate excitotoxicity. Gynecol Endocrinol 22:355-361.
113. North American Menopause Society (2004) The menopause practice: a clinician's guide. http://www.menopause.org/aboutmeno/overview.htm.
114. Pfaff DW (1980) Estrogens and brain function: neural analysis of a hormone-controlled mammalian reproductive behavior. New York: Springer.
115. Pike CJ (1999) Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 72:1552-1563.
116. Purnelle G, Gerard A, Czajkowski V, Bourguignon JP (1997) Pulsatile secretion of gonadotropin-releasing hormone by rat hypothalamic explants without cell bodies of GnRH neurons. Neuroendocrinology 66:305-312.
117. Rapp PR, Morrison JH, Roberts JA (2003a) Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 23:5708-5714.
118. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D (2003b) Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2663-2672.
119. Resnick SM, Henderson VW (2002) Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 288:2170-2172.
120. Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH, Granek IA, Hogan P, Ockene JK, Shumaker SA (2006) Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 91:1802-1810.
121. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333.
122. Rubin BS, Bridges RS (1989) Alterations in luteinizing hormone-releasing hormone release from the mediobasal hypothalamus of ovariectomized, steroid-primed middle-aged rats as measured by push-pull perfusion. Neuroendocrinology 49:225-232.
123. Rubin BS, Lee CE, King JC (1994) A reduced proportion of luteinizing hormone (LH)-releasing hormone neurons express Fos protein during the preovulatory or steroid-induced LH surge in middle-aged rats. Biol Reprod 51:1264-1272.
124. Rudick CN, Woolley CS (2001) Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci 21:6532-6543.
125. Rudick CN, Gibbs RB, Woolley CS (2003) A role for the basal forebrain cholinergic system in estrogen-induced disinhibition of hippocampal pyramidal cells. J Neurosci 23:4479-4490.
126. Santoro N (2005) The menopausal transition. Am J Med 118:8-13.
127. Sarrel P, Dobay B, Wiita B (1998) Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 43:847-856.
128. Savonenko AV, Markowska AL (2003) The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience 119:821-830.
129. Schmidt PJ (2005) Mood, depression, and reproductive hormones in the menopausal transition. Am J Med 118:54-58.
130. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR (2000) Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183:414-420.
131. Schmidt PJ, Haq N, Rubinow DR (2004) A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 161:2238-2244.
132. Schmidt PJ, Palladino-Negro P, Haq N, Gibson C, Rubinow DR (2006) Pharmacologically-induced hypogonadism and sexual function in healthy young women and men. Endocr Soc Abstr 3:553.
133. Setalo Jr G, Singh M, Nethrapalli IS, Toran-Allerand CD (2005) Protein kinase C activity is necessary for estrogen-induced Erk phosphorylation in neocortical explants. Neurochem Res 30:779-790.
134. Sherwin BB (1985) Changes in sexual behavior as a function of plasma sex steroid levels in post-menopausal women. Maturitas 7:225-233.
135. Sherwin BB (1991) The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72:336-343.
136. Sherwin BB (2003) Estrogen and cognitive functioning in women. Endocr Rev 24:133-151.
137. Sherwin BB (2006) Estrogen and cognitive aging in women. Neuroscience 138:1021-1026.
138. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA (2000) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343:682-688.
139. Shivers BD, Harlan RE, Morrell JI, Pfaff DW (1983) Absence of oestradiol concentration in cell nuclei of LHRH-immunoreactive neurons. Nature 304:345-347.
140. Shughrue PJ, Merchenthaler I (2000) Estrogen is more than just a "sex hormone": novel sites for estrogen action in the hippocampus and cerebral cortex. Front Neuroendocrinol 21:95-101.
141. Shumaker SA, Rapp SR, Espeland MA, Wallace RB, Hendrix SL, Henderson VW, Gass ML, Thal L (2003a) Effects of estrogen plus progestin on risk of dementia - reply. JAMA 290:1707-1708.
142. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones III BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J (2003b) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662.
143. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291:2947-2958.
144. Simerly RB, Swanson LW (1987) The distribution of neurotransmitter- specific cells and fibers in the anteroventral periventricular nucleus: Implications for the control of gonadotropin secretion in the rat. Brain Res 400:11-34.
145. Simerly RB, Chang C, Muramatsu M, Swanson LW (1990) Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 294:76-95.
146. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S (2005) Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90:5226-5233.
147. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541.
148. Simpkins JW, Wang J, Wang X, Perez E, Prokai L, Dykens JA (2005) Mitochondria play a central role in estrogen-induced neuroprotection. Curr Drug Targets CNS Neurol Disord 4:69-83.
149. Singh M (2001) Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine 14:407-415.
150. Singh M, Setalo Jr G, Guan X, Frail DE, Toran-Allerand CD (2000) Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice. J Neurosci 20:1694-1700.
151. Singh M, Dykens JA, Simpkins JW (2006) Novel mechanisms for estrogen-induced neuroprotection. Exp Biol Med (Maywood) 231:514-521.
152. Soares CN, Almeida OP, Joffe H, Cohen LS (2001) Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58:529-534.
153. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432.
154. Tang Y, Minwalla L, Janssen WGM, Adams MM, McKay H, Roberts JA, Hof PR, Rapp PR, Morrison JH (2004a) Effects of estrogen on excitatory synapses in hippocampal CA1 of aged female rhesus monkeys. Soc Neurosci Abstr 30:757.16.
155. Tang Y, Janssen WG, Hao J, Roberts JA, McKay H, Lasley B, Allen PB, Greengard P, Rapp PR, Kordower JH, Hof PR, Morrison JH (2004b) Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb Cortex 14:215-223.
156. Tinkler GP, Tobin JR, Voytko ML (2004) Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys. J Comp Neurol 469:507-521.
157. Toran-Allerand CD (2004) Minireview: a plethora of estrogen receptors in the brain: where will it end? Endocrinology 145:1069-1074.
158. Toran-Allerand CD, Singh M, Setalo Jr G (1999) Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrinol 20:97-121.
159. Turgeon JL, McDonnell DP, Martin KA, Wise PM (2004) Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304:1269-1273.
160. Voytko ML (2002) Estrogen and the cholinergic system modulate visuospatial attention in monkeys (Macaca fascicularis). Behav Neurosci 116:187-197.
161. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J (2004) Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med 164:289-298.
162. Weiland NG (1992) Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 131:662-668.
163. Wiegand SJ, Terasawa E, Bridson WE (1978) Persistent estrus and blockade of progesterone-induced LH release follows lesions which do not damage the suprachiasmatic nucleus. Endocrinology 102:1645-1648.
164. Wiklund I, Karlberg J, Mattsson LA (1993) Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 168:824-830.
165. Woods NF, Mitchell ES, Adams C (2000) Memory functioning among midlife women: observations from the Seattle Midlife Women's Health Study. Menopause 7:257-265.
166. Woolley CS, McEwen BS (1992) Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12:2549-2554.
167. Woolley CS, McEwen BS (1993) Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 336:293-306.
168. Woolley CS, McEwen BS (1994) Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 14:7680-7687.
169. Woolley CS, Gould E, Frankfurt M, McEwen BS (1990) Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 10:4035-4039.
170. Woolley CS, Wenzel HJ, Schwartzkroin PA (1996) Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J Comp Neurol 373:108-117.
171. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA (1997) Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci 17:1848-1859.
172. Wu T, Chen S, Brinton RD (2004) Estrogen membrane receptor imaging coupled with estradiol activation of intracellular calcium rise and ERK activation in single neurons. Soc Neurosci Abstr 30:659.20.
173. 2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 135:59-72.
174. Yaffe K (2003) Hormone therapy and the brain: deja vu all over again? JAMA 289:2717-2719.
175. Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279:688-695.
176. Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA, Nickelsen T (2001) Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 344:1207-1213.
177. Yaffe K, Krueger K, Cummings SR, Blackwell T, Henderson VW, Sarkar S, Ensrud K, Grady D (2005) Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry 162:683-690.
178. Yaffe K, Vittinghoff E, Ensrud KE, Johnson KC, Diem S, Hanes V, Grady D (2006) Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol 63:945-950.
179. Yildirim M, Janssen WG, Lou WWY, McEwen BS, Milner TA, Morrison JH (2006) Effects of estrogen and aging on distribution of pAkt in CA1 of rat hippocampus. Soc Neurosci Abstr 32:659.1.
180. Yin W, Gore AC (2006) Neuroendocrine control of reproductive aging: roles of GnRH neurons. Reproduction 131:403-414.
181. Yin W, Oung T, Ng CL, Janssen WGM, Morrison JH, Gore AC (2002) Novel subcellular localization of NMDA receptors (NMDARs) within neuroendocrine GnRH terminals. Soc Neurosci Abstr 28:368.10.
182. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JC (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288:2123-2129.
183. Zhao L, Brinton R (2006a) Estrogen receptor beta as a therapeutic target for promoting neurogenesis and preventing neurodegeneration. Drug Dev Res 66:103-117.
184. Zhao L, Brinton R (2006b) Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosci 7:24.
185. Zhao L, O'Neill K, Diaz Brinton R (2005a) Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Res Brain Res Rev 49:472-493.
186. 2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism. Neuroscience 132:299-311.
187. Znamensky V, Akama KT, McEwen BS, Milner TA (2003) Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J Neurosci 23:2340-2347.
188. Zweifel JE, O'Brien WH (1997) A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22:189-212.